Anesthesia Endotracheal Tube Market to Surpass US$ 289.8 Mn by 2030

Global Anesthesia Endotracheal Tube Market, by Product Type (Nasotracheal Tubes and Orotracheal Tubes), by End User (Hospitals and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 178.7 Million in 2022 and is expected to exhibit a CAGR of 6.2% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Increasing incidence of cardiovascular diseases, chronic diseases, and cancer are expected to increase the number of surgical procedures, which in turn is expected to fuel growth of the anesthesia endotracheal tubes market during the forecast period.  For instance, in 2018, according to data published by the Cancer Research U.K., there were 17 million new cases of cancer worldwide in 2018. Worldwide there will be 27.5 million new cases of cancer each year by 2040. Moreover, according to National Center for Biotechnology Information, in 2021, the annual number of deaths from CVD in India is projected to rise from 2.26 million (1990) to 4.77 million (2020). Coronary heart disease prevalence rates in India have been estimated over the past several decades and have ranged from 1.6% to 7.4% in rural populations and from 1% to 13.2% in urban populations. Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three quarters of CVD deaths take place in low- and middle-income countries.

Global Anesthesia Endotracheal Tube Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, the COVID-19 pandemic had a positive impact on the global anesthesia endotracheal tube market, owing to its possible association like providing oxygen supply to lungs, proper ventilation, and maintenance of the airway passage with the COVID-19 infection. For instance, according to an article published by the National Center for Biotechnology Information, a series of databases relevant to biotechnology and biomedicine, in November 2021, the pneumonia associated with novel coronavirus disease 2019 (COVID-19 or nCoV) may lead to respiratory failure with profound hypoxemia requiring endotracheal intubation and mechanical ventilation. Regional surges in the pandemic resulted in utilization of all available intensive care unit (ICU) ventilators in some institutions. Repurposing of anesthesia machines for longer-term ventilation of COVID-19 or other critically ill patients is feasible, but somewhat unprecedented. Administration of inhalation anesthetics for sedation during longer-term ventilation with anesthesia machines has also been reported in a few institutions. All adjustments of anesthesia machine ventilator and fresh gas flow (FGF) settings are made by an anesthesia professional. This "hands-on," approach requires donning and doffing personal protective equipment (PPE) when caring for a COVID-19 patient. Modification of one anesthesia machine model by reattaching the control and monitoring screen using a special extension cable allows changes to ventilation parameters from outside of the patient's room.

Global Anesthesia Endotracheal Tube Market: Key Developments

In May 2022, Medtronic plc. , a medical device company, launched its new product Shiley Evac Endotracheal Tube with TaperGuard Cuff. The Shiley Evac Endotracheal Tube with TaperGuard Cuff reduces ventilator-associated pneumonia (VAP) by an average of 50%. The need to reduce ventilator associated events is the primary reason the Shiley evac oral endotracheal tube with TaperGuard cuff is critical for all patients on a ventilator in the ICU. Subglottic secretion drainage (SSD) helps remove oral and/or gastric secretions from above the endotracheal tube cuff before they can be aspirated. Such aspirations may lead to a very serious complication known as VAP or Ventilator Associated Pneumonia.

Browse 23 Market Data Tables and 19 Figures spread through 157 Pages and in-depth TOC on “Global Anesthesia Endotracheal Tube Market”- Forecast to 2030, Global Anesthesia Endotracheal Tube Market, by Product Type (Nasotracheal Tubes and Orotracheal Tubes), by End User (Hospitals and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights related to the Global Anesthesia Endotracheal Tube Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/anesthesia-endotracheal-tube-market-2025

Manufacturers are engaged in expanding their services through online pharmacies platform so that maximum end users can access their product and in turn help them to gain more sales. Online marketing services help manufacturers to minimize distribution, set-up, and operational costs. Several online service vendors such as IndiaMART and MedicalExpo sell anesthesia disposables products online. Vendors, such as Medplus and Armstrong Medical also sell anesthesia disposables products through online platforms. They also deliver discounts and promotional offers to increase the number of online purchases. Such platforms provide a significant advantage for anesthesia endotracheal tubes which can be purchased in bulk by hospitals or ambulatory surgical centers at effective prices and in turn help manufacturers to gain the substantial volume growth and value returns.

Key Takeaways of the Global Anesthesia Endotracheal Tube Market:

• Global anesthesia endotracheal tube market is expected to exhibit a CAGR of 6.2% during the forecast period due to increasing launches of new products by key players in market. For instance, in January 2019, Mindray Medical International Limited, a medical instrumentation developer, new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art family of anesthesia solutions.
• Among regions, North America is estimated to account for the largest market share in the global anesthesia endotracheal tube market over the forecast period, owing to increasing chronic surgeries due to rise in prevalence of cardiovascular diseases and lung cancer . For instance, in April 2022, according to the American Heart Association, one person dies every 34 seconds in the U.S. from cardiovascular disease. About 697,000 people in the U.S. died from heart disease in 2020, which was 1 in every 5 deaths. Coronary heart disease is the most common type of heart disease, killing 382,820 people in 2020. About 20.1 million adults aged 20 and older have Coronary Artery Disease (about 7.2%). Every year, about 805,000 people in the U.S. have a heart attack. Of these, 605,000 are a first heart attack and 200,000 happen to people who have already had a heart attack. Moreover, according to National Center for Biotechnology Information, in 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the U.S., including approximately 350 deaths per day from lung cancer, the leading cause of cancer death.
• Major players operating in the global anesthesia endotracheal tube market include Medtronic Plc, General Electric Company, C. R. Bard, Inc., ConvaTec Group plc, Smith Medical, Inc., KindWell Medical Equipment Co.,Ltd, Royax, Fuji Systems Corp., Teleflex Incorporated., Neurovision Medical Products, and Intersurgical GmbH